References
- Allison, L., & Moncrieff, J. (2014). ‘Rapid tranquillisation’: an historical perspective on its emergence in the context of the development of antipsychotic medications. History of psychiatry, 25(1), 57–69.
- Artigas-Pallarés, J. (2006). Pharmacological treatment of mental retardation. Revista de Neurologia, 42(S1): S109–S115.
- Bellino, S., Rinaldi, C., Bozzatello, P., & Bogetto, F. (2011). Pharmacotherapy of borderline personality disorder: A systematic review. Current medicinal chemistry, 18(22), 3322–3329.
- Bhana, A., Mntambo, N., Gigaba, S. G., Luvuno, Z. P. B., Grant, M., Ackerman, D., ... & Petersen, I. (2019). Validation of a brief mental health screening tool for common mental disorders in primary healthcare. SAMJ: South African Medical Journal, 109(4), 278–283.
- Cannella, N., Ubaldi, M., Masi, A., Bramucci, M., Roberto, M., Bifone, A., & Ciccocioppo, R. (2019). Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. Neuroscience & Biobehavioral Reviews [Epub ahead of print].
- Castaldelli-Maia, J. M., Andrade, L. H., Keyes, K. M., Cerdá, M., Pilowsky, D. J., & Martins, S. S. (2016). Exploring the latent trait of opioid use disorder criteria among frequent nonmedical prescription opioid users. Journal of psychiatric research, 80, 79–86.
- Castaldelli-Maia, J. M., Andrade, L. H., Storr, C. L., Viana, M. C., Andrade, A. G., & Martins, S. S. (2018a). The latent trait of ICD-11 nicotine dependence criteria: Dimensional and categorical phenotypes. Psychiatry research, 266, 275–283.
- Castaldelli-Maia, J. M., Martins, S. S., & Walker, N. (2018b). The effectiveness of Cytisine versus Nicotine Replacement Treatment for smoking cessation in the Russian Federation. The International journal on drug policy, 58, 121–125.
- Castaldelli-Maia, J. M., Wang, Y. P., Borges, G., Silveira, C. M., Siu, E. R., Viana, M. C., ... & Andrade, L. H. (2015). Investigating dimensionality and measurement bias of DSM-5 alcohol use disorder in a representative sample of the largest metropolitan area in South America. Drug and alcohol dependence, 152, 123–130.
- Citrome, L. (2016). Emerging pharmacological therapies in schizophrenia: what’s new, what’s different, what’s next?. CNS spectrums, 21(S1), 1–12.
- Cook Jr, E. H., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child & Adolescent Psychiatry, 31(4), 739–745.
- Corrigan, P. W., Watson, A. C., Heyrman, M. L., Warpinski, A., Gracia, G., Slopen, N., & Hall, L. L. (2005). Structural stigma in state legislation. Psychiatric Services, 56(5), 557–563.
- Degenhardt, L., Bharat, C., Bruno, R., Glantz, M. D., Sampson, N. A., Lago, L., ... & Caldas-de-Almeida, J. M. (2019). Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO’s World Mental Health Surveys. Addiction, 114(3), 534–552.
- DeLuca, J. S., & Clement, T. (2017). Does individual stigma predict mental health funding attitudes? Toward an understanding of resource allocation and social climate. The Israel journal of psychiatry and related sciences, 54(1), 6–17.
- Estrada-Orozco, K., Bonilla-Vargas, K., Cruz, F., Mancera, O., Ruiz, M., Alvarez, L., ... & Arboleda, H. (2018). Cognitive assessment test: validation of a short cognitive test for the detection of mild cognitive disorder. International Journal of Alzheimer’s Disease, 2018, 3280621.
- Falagas, M. E., Pitsouni, E. I., Malietzis, G. A., & Pappas, G. (2008). Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. The FASEB journal, 22(2), 338–342.
- Fowler, B. M. (2019). Clinical Education to Decrease Perceived Barriers to Delirium Screening in Adult Intensive Care Units. Critical care nursing quarterly, 42(1), 41–43.
- Frandsen, T. F., Eriksen, M. B., Hammer, D. M. G., & Christensen, J. B. (2019). PubMed coverage varied across specialties and over time: a large-scale study of included studies in Cochrane reviews. Journal of clinical epidemiology, 112, 59–66.
- Franklin, J. M., & Schneeweiss, S. (2017). When and how can real world data analyses substitute for randomized controlled trials?. Clinical Pharmacology & Therapeutics, 102(6), 924–933.
- Gamache, D., Savard, C., Lemelin, S., Côté, A., & Villeneuve, É. (2018). Premature Termination of Psychotherapy in Patients With Borderline Personality Disorder: A Cluster-Analytic Study. The Journal of nervous and mental disease, 206(4), 231–238.
- Grossman, J., & Mackenzie, F. J. (2005). The randomized controlled trial: gold standard, or merely standard?. Perspectives in biology and medicine, 48(4), 516–534.
- Halladay, C. W., Trikalinos, T. A., Schmid, I. T., Schmid, C. H., & Dahabreh, I. J. (2015). Using data sources beyond PubMed has a modest impact on the results of systematic reviews of therapeutic interventions. Journal of clinical epidemiology, 68(9), 1076–1084.
- Harris, M., Chandran, S., Chakraborty, N., & Healy, D. (2005). The impact of mood stabilizers on bipolar disorder: the 1890s and 1990s compared. History of Psychiatry, 16(4), 423–434.
- Hasan, A., Bandelow, B., Yatham, L. N., Berk, M., Falkai, P., Möller, H. J., ... & WFSBP Guideline Task Force Chairs. (2019). WFSBP guidelines on how to grade treatment evidence for clinical guideline development. The World Journal of Biological Psychiatry, 20(1), 2–16.
- Hemayattalab, R., & Movahedi, A. (2010). Effects of different variations of mental and physical practice on sport skill learning in adolescents with mental retardation. Research in developmental disabilities, 31(1), 81–86.
- Hockenberry, J. M., Joski, P., Yarbrough, C., & Druss, B. G. (2019). Trends in treatment and spending for patients receiving outpatient treatment of depression in the United States, 1998–2015. JAMA psychiatry, 76(8), 810–817.
- Holzapfel, E. M., & Szabo, C. P. (2018). Pharmacotherapy prescribing patterns in the treatment of bipolar disorder in a South African outpatient population. Global Psychiatry, 1(2), 39–51.
- Hoogendam, A., de Vries Robbe, P. F., Stalenhoef, A. F., & Overbeke, A. J. P. (2009). Evaluation of PubMed filters used for evidence-based searching: validation using relative recall. Journal of the Medical Library Association: JMLA, 97(3), 186.
- Huang, Y. J., Lane, H. Y., & Lin, C. H. (2017). New treatment strategies of depression: based on mechanisms related to neuroplasticity. Neural plasticity, 2017, 4605971.
- Koelkebeck, K., Stefanovic, M. P., Frydecka, D., Palumbo, C., Andlauer, O., Riese, F., ... & da Costa, M. P. (2019). Barriers and facilitators to conducting research by early career psychiatrists: a literature review. Global Psychiatry, 2(2), 135–153.
- Koskinen, J., Isohanni, M., Paajala, H., Jääskeläinen, E., Nieminen, P., Koponen, H., ... & Miettunen, J. (2008). How to use bibliometric methods in evaluation of scientific research? An example from Finnish schizophrenia research. Nordic journal of psychiatry, 62(2), 136–143.
- Kupfersmid, J. (2019). Freud’s Clinical Theories Then and Now. Psychodynamic psychiatry, 47(1), 81–97.
- Lauber, C., Ajdacic-Gross, V., Fritschi, N., Stulz, N., & Rössler, W. (2005). Mental health literacy in an educational elite – an online survey among university students. BMC Public Health, 5(1), 44.
- Little, J. D., McFarlane, J., & Ducharme, H. M. (2002). ECT use delayed in the presence of comorbid mental retardation: a review of clinical and ethical issues. The journal of ECT, 18(4), 218–222.
- Liu, B., Liu, J., Wang, M., Zhang, Y., & Li, L. (2017). From serotonin to neuroplasticity: evolvement of theories for major depressive disorder. Frontiers in cellular neuroscience, 11, 305.
- López-Muñoz, F., Tracy, D. K., Povedano-Montero, F. J., Breedvelt, J., García-Pacios, J., Fernández-Martín, M. P., ... & Álamo, C. (2019). Trends in the scientific literature on atypical antipsychotic drugs in the United Kingdom: a bibliometric study. Therapeutic advances in psychopharmacology, 9, 2045125318820207.
- Machmutow, K., Meister, R., Jansen, A., Kriston, L., Watzke, B., Härter, M. C., & Liebherz, S. (2019). Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults. Cochrane Database of Systematic Reviews, (5), CD012855.
- Manca, A., Cugusi, L., Dvir, Z., & Deriu, F. (2017). PubMed should raise the bar for journal inclusion. The Lancet, 390(10096), 734–735.
- McNamara, C., Engelhardt, N., Potter, W., Yavorsky, C., Masotti, M., & Di Clemente, G. (2019). Risk-Based Data Monitoring: Quality Control in Central Nervous System (CNS) Clinical Trials. Therapeutic innovation & regulatory science, 53(2), 176–182.
- Möller-Leimkühler, A. M., Möller, H. J., Maier, W., Gaebel, W., & Falkai, P. (2016). EPA guidance on improving the image of psychiatry. European archives of psychiatry and clinical neuroscience, 266(2), 139–154.
- Newton-Howes, G., Tyrer, P., Johnson, T., Mulder, R., Kool, S., Dekker, J., & Schoevers, R. (2014). Influence of personality on the outcome of treatment in depression: systematic review and meta-analysis. Journal of Personality Disorders, 28(4), 577–593.
- Overholser, J. C. (2002). Treatments for depression: wisdom imparted from treatments discarded. The International Journal of Psychiatry in Medicine, 32(4), 317–336.
- Reed, G. M. (2010). Toward ICD-11: Improving the clinical utility of WHO’s International Classification of mental disorders. Professional Psychology: Research and Practice, 41(6), 457.
- Reed, G. M. (2018). Progress in developing a classification of personality disorders for ICD-11. World Psychiatry, 17(2), 227–229.
- Ross, C. A. (2005). A proposed trial of dialectical behavior therapy and trauma model therapy. Psychological reports, 96(S3), 901–911.
- Sedler, M. J. (2016). Medicalization in psychiatry: the medical model, descriptive diagnosis, and lost knowledge. Medicine, Health Care and Philosophy, 19(2), 247–252.
- Shankman, S. A., Funkhouser, C. J., Klein, D. N., Davila, J., Lerner, D., & Hee, D. (2018). Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM-5 (SCID). International journal of methods in psychiatric research, 27(1), e1590.
- Simeon, D., & Knutelska, M. (2005). An open trial of naltrexone in the treatment of depersonalization disorder. Journal of clinical Psychopharmacology, 25(3), 267–270.
- Skodol, A. E., Geier, T., Grant, B. F., & Hasin, D. S. (2014). Personality disorders and the persistence of anxiety disorders in a nationally representative sample. Depression and Anxiety, 31(9), 721–728.
- Stuhec, M., & Gorenc, K. (2019). Positive impact of clinical pharmacist interventions on antipsychotic use in patients on excessive polypharmacy evidenced in a retrospective cohort study. Global Psychiatry, 2(2), 155–163.
- Stuhec, M., Munda, B., Svab, V., & Locatelli, I. (2015). Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion. Journal of affective disorders, 178, 149–159.
- Thoma, N., Pilecki, B., & McKay, D. (2015). Contemporary cognitive behavior therapy: A review of theory, history, and evidence. Psychodynamic Psychiatry, 43(3), 423–461.
- Tyrer, P. (2009). Why borderline personality disorder is neither borderline nor a personality disorder. Personality and Mental Health, 3(2), 86–95.
- Vogel, R. J. (2002). Pharmaceutical patents and price controls. Clinical therapeutics, 24(7), 1204–1222.
- Wang, J., Chen, Z., Sun, W., Zheng, Y., Hui, L., Liu, X., ... & Zhang, T. (2019). A Strategy to Address High Comorbidity of Personality Disorders in a Chinese Population: A Principal and Subordinate Diagnostic Model. Psychiatry, 82(3), 272–282.
- World Health Organization. (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines (Vol. 1). World Health Organization.
- World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research (Vol. 2). World Health Organization.
- World Health Organization. (1996). Diagnostic and management guidelines for mental disorders in primary care: ICD-10. Chapter 5, Primary care version. World Health Organization.